Research | Hadassah International

Hadassah International Supports the Hadassah Medical Center: More than a Hospital!

Hadassah Study Sheds Encouraging Light in Treating Liver Disease

The International Journal of Molecular Medicine has published a preclinical study led by Prof. Rifaat Safadi, head of the Hadassah Medical Center’s Liver Unit, that finds the oral drug Namodenoson…

Vaginal Microbiome Transplant Proves Effective Against Bacterial Vaginosis

Intervening at the End of Life: What Has Changed?

Cardiovascular Health Literacy: A Hadassah Pollin Center Success Story

Kadimastem Announces Promising Interim Results in ALS Clinical Trial

Gut Microbes May Affect the Course of ALS

Positive Attitude? Less Pain for ALS Patients

Alzheimer’s Further Illuminated at Hadassah with New Exclusive Imaging Agent

Cystic Fibrosis

Eloxx Pharmaceuticals Announces Open Investigational New Drug Application (IND) for Phase 2 Clinical Trial of ELX-02 in Cystic Fibrosis Patients with G542X Mutation

Skin Cancer Treatment Enhanced in Hadassah’s New Center for Dermatologic Surgery, Thanks to Supporter of Israeli Spacecraft Project

Multinational Study Reveals Reduction in Kidney Disease Progression with Diabetes Drug

Diabetes: An Ongoing Struggle

Hadassah Hospital

What Causes PMS? Hadassah Study Offers Answer, with Implications for Future Research

Hadassah Helps IDF Tank Teacher to Live Productively With Diabetes

Hadassah Physician Solves a Medical Mystery, Saving One Little Girl and Then Many More

Cancer Immunotherapy

A New Collaborative Relationship is Formed between Hospital Israelita Albert Einstein in Brazil and Hadassah Medical Center

First in the World

Hadassah Hospital Specialist and Hebrew University Researcher Use Phage Therapy to Save Leg of Accident Victim

Pre-clinical Study by Hadassah Neurologists Sheds Light on Major Player in Alzheimer’s Disease

Hadassah Cardiac Specialist Recognized for Lifetime Achievement

Hadassah Researchers Identify Defective Genetic Pathway Leading to Heart Abnormality